Story
9 Okt 2008
Major drug firms agree with Ban Ki-Moon to invest more in AIDS treatments & diagnostics for poor regions
Alle Tags anzeigen
Alle Tags anzeigen
Abbott Laboratories
Aspen Pharmacare
AMB Generali
Aurobindo Pharmaceuticals
bioMérieux
BD (Becton, Dickinson)
Boehringer Ingelheim
GlaxoSmithKline
Gilead Sciences
Hetero
Inverness Medical Innovations
Johnson & Johnson
Merck
Matrix Laboratories (part of Mylan Laboratories)
Pfizer
Roche
Ranbaxy Laboratories
Shanghai Kehua Bio-Engineering